Pharmaceuticals, Biotechnology and Life Sciences
“EvaluatePharma® World Preview 2019, Outlook to 2024” explores growth drivers, growth brakes and top industry performers. LONDON & BOSTON &…
New International Team Brings Extensive Ocular Drug Delivery and Scientific Expertise to Advance the Sustained Release of Biologics and Small…
New product will be the market’s first and only to enable optimization of ALL diabetes medications, insulin and non-insulin alike.…
Seed round led by Playground Global to focus on the advancement of next-generation mRNA-based cancer immunotherapies and development of its…
Phase Ib/II Clinical Trial Data Reported at 2019 Annual Meeting of the American Society of Clinical Oncology Shows High Overall…
U.S. Food and Drug Administration grants priority review for beta-thalassemia indication and sets target action date of December 4, 2019…
WILMINGTON, Del.–(BUSINESS WIRE)–$INCY–Incyte (Nasdaq:INCY) today announced that the first patient has been treated in FIGHT-302, an open-label Phase 3 study…
Kraig Labs R&D Team continues to deliver outstanding breakthroughs ANN ARBOR, Mich.–(BUSINESS WIRE)–$KBLB #KBLB–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”),…
— Company Expands Management Team and Bolsters Commercial Capabilities to Support Continued Growth — CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq:DRNA)…
– KVD900 Demonstrates Rapid and Nearly Complete Suppression of Plasma Kallikrein Activity in a Phase 1 Study – CAMBRIDGE, Mass.…